DAIICHI SANKYO ILACTICARET LIMITED SIRKETI

Company Type: Trader

Company Introduction:

DAIICHI SANKYO ILACTICARET LIMITED SIRKETI is the Turkish subsidiary of Daiichi Sankyo, a leading global pharmaceutical company headquartered in Japan. This entity primarily operates as the sales, marketing, and distribution arm for Daiichi Sankyo's pharmaceutical products within Turkey. Its core activities involve the import, commercialization, and supply of innovative medicines to the Turkish market, catering to healthcare professionals and patients. While Daiichi Sankyo maintains manufacturing facilities globally, the Turkish "Ilact ticaret" (pharmaceutical trade) entity is established to manage the commercial operations, market access, and regulatory affairs for the group's portfolio in the region.

Here are some of the products manufactured or marketed by DAIICHI SANKYO ILACTICARET LIMITED SIRKETI in Turkey:

* Lixiana (Edoxaban)

* Effient (Prasugrel)

* Olmetec (Olmesartan Medoxomil)

* Sevikar (Olmesartan Medoxomil/Amlodipine)

* Tribenzor (Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide)

* Benicar (Olmesartan Medoxomil)

* Movalis (Meloxicam)

* Oxycontin (Oxycodone)

* Targinact (Oxycodone/Naloxone)

Note: Product availability may vary and this list may not be exhaustive.